FIND PERSONALIZED JOBS
Sign up to Zippia and discover your career options with your personalized career search.
Sorry, we can't find that. Please try a different city or state.
APPLY NOW
Apply Now
×
FIND
PERSONALIZED JOBS

Sorry, we can't find that. Please try a different city or state.

CONTENT HAS
BEEN UNLOCKED
Close this window to view unlocked content
or
find interesting jobs in

Log In

Log In to Save

Sign Up to Save

Sign Up to Dismiss

Sign Up

SIGN UP TO UNLOCK CONTENT

or

The email and password you specified are invalid. Please, try again.

Email and password are mandatory

Forgot Password?

Don't have an account? Sign Up

reset password

Enter your email address and we will send you a link to reset your password.

Back to Log In

Log In

Log In to Save

Sign Up to Save

Sign Up to Dismiss

Sign up to save the job and get personalized job recommendations.

Sign up to dismiss the job and get personalized job recommendations.

or

The email and password you specified are invalid. Please, try again.

Email and password are mandatory

Already have an account? Log in

reset password

Enter your email address and we will send you a link to reset your password.

Back to Log In

Company Saved

Answer a few questions and view jobs at CTI BioPharma that match your preferences.

Where do you want to work?

Job Saved

See your Saved Jobs now

or

find more interesting jobs in

Job Dismissed

Find better matching jobs in

Your search has been saved!

Pharmaceuticals, Biotechnology & Life Sciences Logo
SIGN UP
  • Sign up with Facebook
  • Sign up with Google
We will never post anything without your permission.
Creating an account means you're okay with our terms of service and privacy policy.

Already have an account? Login

Working At CTI BioPharma

Zippia Score 4.5

Review Submitted!

CTI BioPharma

CTI BioPharma Overview

Industry

Biotechnology

Organization Type

Public

Employees

104

Headquarters

Seattle, WA

Website

ctibiopharma.com

Website

ctibiopharma.com



Founded in

1991

Revenue

$36.5M

Key People

James Bianco (founder)

Show More

About CTI BioPharma

CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma in the European Union. The company is also developing Pacritinib, an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R, which is in Phase Phase III clinical trials for the treatment of myelofibrosis. In addition, it is developing Tosedostat, an oral once-daily aminopeptidase inhibitor that is in Phase II clinical trials for the treatment of acute myeloid leukemia. The company has license and collaboration agreement with Les Laboratoires Servier and Institut de Recherches Internationales Servier; development, commercialization, and license agreement with Baxter International Inc.; agreement with the University of Vermont, BIO Pte Ltd., Gynecologic Oncology Group, and PG-TXL Company, L.P; and license agreement with Vernalis (R&D) Limited. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was founded in 1991 and is headquartered in Seattle, Washington.

Show More

CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma in the European Union. The company is also developing Pacritinib, an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R, which is in Phase Phase III clinical trials for the treatment of myelofibrosis. In addition, it is developing Tosedostat, an oral once-daily aminopeptidase inhibitor that is in Phase II clinical trials for the treatment of acute myeloid leukemia. The company has license and collaboration agreement with Les Laboratoires Servier and Institut de Recherches Internationales Servier; development, commercialization, and license agreement with Baxter International Inc.; agreement with the University of Vermont, BIO Pte Ltd., Gynecologic Oncology Group, and PG-TXL Company, L.P; and license agreement with Vernalis (R&D) Limited. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was founded in 1991 and is headquartered in Seattle, Washington.

Show More

What Is

CTI BioPharma's Mission Statement

?
To acquire, develop and bring to market less toxic, more effective therapies to treat and cure cancer.

Is This Your Company?

Do You Work At CTI BioPharma?

CTI BioPharma Careers

Average Length of Employment
ROBBINS GIOIA 4.5 years

CTI BioPharma

3.7 years
Genzyme 3.5 years
Centocor 3.5 years
Allos Therapeutics 2.6 years
Gilead Sciences 2.3 years
FibroGen 2.1 years
Alcami 1.9 years
Seattle Genetics 1.9 years
CEDRA 1.8 years
Pharmacyclics 1.4 years

What is it like to work at CTI BioPharma

CTI BioPharma Employees Education

Schools

University of Washington

19.0%

University of Minnesota - Crookston

9.5%

North Dakota State University -

4.8%

Northwestern University

4.8%

University of California - Merced

4.8%

Edinboro University of Pennsylvania

4.8%

ITT Technical Institute-Seattle

4.8%

Shoreline Community College

4.8%

Seattle University

4.8%

Pennsylvania State University

4.8%

Seattle Central Community College

4.8%

Edmonds Community College

4.8%

University of California - Los Angeles

4.8%

University of Delaware

4.8%

Western Governors University

4.8%

Wake Forest University

4.8%

University of California - Irvine

4.8%
Show More
Majors

Biology

8.3%

Chemistry

8.3%

Computer Science

8.3%

Environmental Control Technologies/Technicians

8.3%

General Studies

8.3%

Health Care Administration

4.2%

Nursing

4.2%

Environmental Science

4.2%

Public Relations

4.2%

General Education, Specific Areas

4.2%

Journalism

4.2%

General Sales

4.2%

Microbiology

4.2%

Health/Medical Preparatory Programs

4.2%

Biochemistry, Biophysics, Molecular Biology

4.2%

Medicine

4.2%

Human Resources Management

4.2%

Information Technology

4.2%

Chemical Engineering

4.2%
Show More
Degrees

Bachelors

37.5%

Masters

16.7%

Associate

16.7%

Other

12.5%

Certificate

8.3%

Doctorate

8.3%
Show More

How Would You Rate Working At CTI BioPharma?

Are you working at CTI BioPharma? Help us rate CTI BioPharma as an employer.

CTI BioPharma Salaries

  • -
    Salary Score
We calculated the salary score by comparing the salaries of specific positions within a given company against other similar positions at other similar companies.
Safety ManagerSeattle, WA $110,351

No Results

To get more results, try adjusting your search by changing your filters.

Show More

CTI BioPharma Awards

Awards From Zippia
  • Best Paying Companies In 2019

CTI BioPharma Stock Performance

  • -
    Performance Score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Revenue

$36.5M

Net Income

-

Market Cap

$96,760,000

Total Equity

-

Total Assets

-

How Would You Rate The Company Culture Of CTI BioPharma?

Have you worked at CTI BioPharma? Help other job seekers by rating CTI BioPharma.

CTI BioPharma Competitors

Competitors Jobs

NO RESULTS

Aw snap, no jobs found.

Frequently Asked Questions about CTI BioPharma

When was CTI BioPharma founded?

CTI BioPharma was founded in 1991.

How many Employees does CTI BioPharma have?

CTI BioPharma has 104 employees.

How much money does CTI BioPharma make?

CTI BioPharma generates $36.5M in revenue.

What industry is CTI BioPharma in?

CTI BioPharma is in the biotechnology industry.

What is CTI BioPharma's mission?

CTI BioPharma's mission statement is "To acquire, develop and bring to market less toxic, more effective therapies to treat and cure cancer."

What type of company is CTI BioPharma?

CTI BioPharma is a public company.

Who are CTI BioPharma's competitors?

CTI BioPharma competitors include Seattle Genetics, NanoString Technologies, Gilead Sciences, Puma Biotechnology, Pharmacyclics, Emergent BioSolutions, Allos Therapeutics, REGISTRAT, ROBBINS GIOIA, PDL Biopharma, FibroGen, Amicus Therapeutics, AAIPharma Services Corp, MannKind Corporation, Genzyme, Icon Clinical Research, Centocor, Alcami, Im Clone Systems Inc., CEDRA.

Who works at CTI BioPharma?

James Bianco (founder)

Show More

You can find out what it is like to work at CTI BioPharma, also known as CTI BIOPHARMA CORP, CTI BioPharma, CTI BioPharma Corp and CTI BioPharma Corp..

Zippia gives an in-depth look into the details of CTI BioPharma, including salaries, political affiliations, employee data, and more, in order to inform job seekers about CTI BioPharma. The employee data is based on information from people who have self-reported their past or current employments at CTI BioPharma. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions, or for the results obtained from the use of this information. The data presented on this page does not represent the view of CTI BioPharma and its employees or that of Zippia.